References
- Hu SS, Wang ZW. Overview of China cardiovascular health and disease report 2022. Chin J Card Dise. 2019;21(07):577–600.
- Hohendanner F, Heinzel FR, Blaschke F, et al. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail Rev. 2018;23:27–28. doi:10.1007/s10741-017-9657-9
- Zhao ZH, Zhang XG. Atrial fibrillation epidemiological investigation 20 years China [J]. Chin J Card Pacem Elect Phys. 2023;5(3):232–235.
- Huang C. Atrial fibrillation: current understanding and treatment recommendations-2018. Chin J Card Pac Elect. 2018;32(04):333.
- Zhang YY, Qiu C, Davis PJ, et al. Predictors of progression of recently diagnosed atrial fibrillation in registry on cardiac rhythm disorders assessing the control of atrial fibrillation (RecordAF)-United States cohort. Am J Cardio. 2013;112(1):79–84. doi:10.1016/j.amjcard.2013.02.056
- Fu DJ, He J, Zhang XY. Analysis of risk factors for thrombosis in patients with nonvalvular atrial fibrillation. Chin J Circ. 201227(4):282.
- Xu YY. Correlation analysis of plasma D-D, Fg levels and left atrial size in patients with coronary heart disease and atrial fibrillation. J Bengbu Med Colle. 2019;48(2):226–229.
- Yin YH LJY, Liu JW. The relationship and significance of red blood cell distribution width, galactose agglutinin 3 and neutrophil lymphocyte ratio with coronary heart disease complicated with atrial fibrillation. Chin J Card Dise. 2023;21(01):40–44.
- Han YL, Gao W, Fu XH. Guidelines for diagnosis and treatment of stable coronary heart disease. Chin J Cardio. 2018;46(9):680–694.
- Ma CS, Wu SL, Liu SW, et al. Chinese guidelines for diagnosis and treatment of atrial fibrillation. Chin J Cardio. 2019;51(6):572–618.
- Zeng Y, Zhao J, Zhang J, et al. Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia. J Cardiovasc Pharmacol Ther. 2023;28(107424842311677):54. doi:10.1177/10742484231167754
- Wang YB, Wu YJ. Clinical characteristics and related progress of stroke prevention and treatment in patients with coronary heart disease complicated with atrial fibrillation. Chin J Circu. 2018;33(12):1239–1241.
- Gizurarson S, Stahlman M, Jeppsson A, et al. Atrial fibrillation in patients admitted to coronary care units in western Sweden-focus on obesity and lipotoxicity. J Elect. 2015;48(5):853–860.
- Lamblin N, Meurice T, Tricot O, et al. First hospitalization for heart Failure in outpatients with stable coronary artery disease: Determinants, Role of incident myocardial infarction, and prognosis. J Card Fail. 2018;24(12):815–822. doi:10.1016/j.cardfail.2018.09.013
- Tian Y, Wei XY, Chen YL, et al. Meta-analysis of risk factors for new atrial fibrillation after acute myocardial infarction. J Card Vasc Dis. 2019;38(12):1275–1279.
- Mallikarjuna R, Edupuganti M, Marmagkiolis K, et al. Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation. Card Rev Med. 2014;15(8):414–420.
- Zhang LJ, Wei XY, Lu JQ, et al. Lasso regression: from Interpretation to Prediction. Adv Psych Sci. 2020;28(10):1777–1791. doi:10.3724/SP.J.1042.2020.01777
- Zhang J, Johnsen SP, Guo Y, et al. Epidemiology of atrial fibrillation: Geographic/ecological risk factors, age, sex, genetics. Card Elect Clin. 2021;13(1):1–23.
- Menichelli D, Sciacqua A, Cangemi R, et al. ATHERO-AF study group. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study. Int J Clin Pract. 2021;75(3):e13771. doi:10.1111/ijcp.13771
- Chou H, Chen H, Xie J, et al. Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients. Front Physiol. 2020;11:580624. doi:10.3389/fphys.2020.580624
- Rezaei Y, MM P, Naghshbandi S, et al. Postoperative atrial fibrillation following cardiac surgery: from pathogenesis to potential therapies. Am J Card Drug. 2020;20(1):19–49.
- Carlisle MA, Fudim M, DeVore AD, et al. Heart Failure and Atrial Fibrillation. JACC Heart Fail. 2019;7(6):447–456. doi:10.1016/j.jchf.2019.03.005
- Xu Q, Peng Y, Tan J, et al. Prediction of atrial fibrillation in hospitalized elderly patients with coronary heart disease and type 2 diabetes mellitus using machine learning: a multicenter retrospective study. Front Public Health. 2022;10:842104. doi:10.3389/fpubh.2022.842104
- Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):21. doi:10.1038/s41572-022-00347-9
- Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Card. 2014;64(3):281–289. doi:10.1016/j.jacc.2014.03.048
- Elliott AD, Gallagher C, Middeldorp ME, et al. Drinking to atrial fibrillation: alcohol and atrial fibrillation incidence. Europ. 2020;22(2):177–178.
- Nattel S, Dobrev D. Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century. Card Res. 2016;109(4):465–466. doi:10.1093/cvr/cvw028
- Hiram R, Provencher S. Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation. Card Elect Clin. 2021;13(1):141–153.
- Chalkou K, Vickers AJ, Pellegrini F, Manca A, Salanti G. Decision curve analysis for personalized treatment choice between multiple options. Med Decis Making. 2023;43(3):337–349. doi:10.1177/0272989X221143058